INIS
drugs
100%
patients
87%
therapy
53%
levels
38%
india
29%
evaluation
29%
rats
29%
control
29%
hiv
26%
reviews
26%
pharmacotherapy
26%
receptors
26%
kidneys
26%
management
26%
interactions
25%
inflammation
25%
breasts
22%
antioxidants
20%
toxicity
20%
diseases
19%
comparative evaluations
19%
asthma
17%
psychological behavior
17%
monitoring
17%
proteins
17%
morbidity
16%
skin
16%
males
16%
liver
16%
humans
16%
assessments
16%
cancer
16%
injuries
16%
damage
15%
antidepressants
13%
WHO
13%
implementation
13%
genes
13%
psychoses
13%
children
13%
women
13%
quality of life
13%
viruses
13%
papayas
13%
acetic acid
13%
workers
13%
covid-19
13%
aluminium chlorides
13%
nervous system diseases
13%
phosphates
13%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
40%
Pharmacotherapy
26%
Asthma
26%
Comorbidity
26%
Adverse Event
19%
Antioxidant
17%
Receptor
15%
Cross-Sectional Study
14%
Disease
14%
Kidney Injury
13%
Drug-Drug Interaction
13%
Papaya
13%
Potassium Acetate
13%
Wistar Rat
13%
Antidepressant
13%
Anxiety Disorder
13%
Risperidone
13%
Granulomatous Mastitis
13%
Hyperprolactinemia
13%
Ulcerative Colitis
13%
Opportunistic Infection
13%
Siponimod
13%
Sphingosine 1 Phosphate Receptor
13%
Cycloserine
13%
Abacavir
13%
Therapeutic Drug Monitoring
13%
Bipolar Disorder
13%
Staphylococcal Scalded Skin Syndrome
13%
Cotrimoxazole
13%
Acute Kidney Failure
13%
Crystalluria
13%
Breast Cancer
13%
Multi-Drug-Resistant Tuberculosis
13%
Allergic Reaction
13%
Ethambutol
13%
Acute Pancreatitis
13%
Ceftriaxone
13%
Toxic Epidermal Necrolysis
13%
Neuropathy
13%
Carboplatin
13%
Anti-Inflammatory Drug
13%
Tribulus terrestris
13%
Interleukin 6
13%
Aluminum Chloride
13%
Malignant Neoplasm
10%
Granulomatous Inflammation
8%
Granulomatosis
8%
Granuloma
8%
Ethionamide
8%
Liver Injury
7%
Medicine and Dentistry
Human Immunodeficiency Virus
26%
Medical Student
21%
Awareness
16%
Antioxidant
15%
Cross Sectional Study
13%
Therapeutic Drug Monitoring
13%
Drug Therapy
13%
Hyperprolactinemia
13%
Opportunistic Infection
13%
Granulomatous Mastitis
13%
Sphingosine 1 Phosphate Receptor
13%
Siponimod
13%
Allergic Response
13%
Abacavir
13%
Risperidone
13%
Bipolar Disorder
13%
Behavioral Change
13%
Cycloserine
13%
Multidrug Resistant Tuberculosis
13%
Ethambutol
13%
Neuropathy
13%
Carboplatin
13%
Antiinflammatory Activity
13%
Aluminum Chloride
13%
Tribulus terrestris
13%
Interleukin 6
13%
Adverse Event
11%
Granulomatous Inflammation
8%
Granulomatosis
8%
Granuloma
8%
Standardized Patient
8%
Checklist
8%
Physician
8%
Ethionamide
8%
Liver Injury
7%
Weakness
5%
Alzheimer's Disease
5%